Evidence map›Paper›PMID 42712907›Full record

ArticleJournal of the Endocrine Society2026

Seiya Suzuki, Yoichi Oikawa, Atsushi Satomura, Akifumi Haisa, Shumpei Nakanishi, Masashi Fujisawa, Hideo Morita, Takeshi Katsuki, Akira Shimada

Abstract read
In one paragraph

Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Seiya SuzukiDepartment of Endocrinology and Diabetes, Saitama Medical University, Saitama 350-0495, Japan.
Yoichi OikawaDepartment of Endocrinology and Diabetes, Saitama Medical University, Saitama 350-0495, Japan.ORCID https://orcid.org/0000-0003-1524-6751
Atsushi SatomuraDepartment of Endocrinology and Diabetes, Saitama Medical University, Saitama 350-0495, Japan.
Akifumi HaisaDepartment of Endocrinology and Diabetes, Saitama Medical University, Saitama 350-0495, Japan.
Shumpei NakanishiDepartment of Endocrinology and Diabetes, Saitama Medical University, Saitama 350-0495, Japan.
Masashi FujisawaDepartment of Endocrinology and Diabetes, Saitama Medical University, Saitama 350-0495, Japan.
Hideo MoritaDepartment of Endocrinology and Diabetes, Saitama Medical University, Saitama 350-0495, Japan.
Takeshi KatsukiDepartment of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo 108-0073, Japan.
Akira ShimadaDepartment of Endocrinology and Diabetes, Saitama Medical University, Saitama 350-0495, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: Unprovoked ketosis-prone type 2 diabetes (KPD) is characterized by a male predominance, young age of onset, and abrupt presentation of diabetic ketosis/ketoacidosis without precipitating factors. Although many individuals regain β-cell function after insulin therapy, some progress to insulin dependence, suggesting overlap with type 1 diabetes. We previously reported the involvement of insulin-associated peptide-specific T helper 1 (Th1) responses in KPD pathogenesis. Exocrine pancreatic inflammation has been documented in type 1 diabetes, with evidence suggesting its contribution to disease development; however, its relevance to KPD remains unclear. Objective: This cross-sectional study aimed to elucidate mechanisms underlying KPD by investigating the association between endocrine and exocrine immune responses. Methods: We recruited 54 participants with KPD, assessed clinical parameters, including human leukocyte antigen ( Results: Conclusion:

Indexed as

carbonic anhydrase II antibodyenzyme-linked immunospot assayinsulininterferon-γketosis-prone type 2 diabetes

Identifiers

PMID42712907
PMCPMC13550934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.